{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:48:01Z","timestamp":1761965281227},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T00:00:00Z","timestamp":1616889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T00:00:00Z","timestamp":1616889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>\u00a0Patients with lymphoproliferative disorders following hematopoietic stem cell transplant (HSCT) most commonly present with fever and lymphadenopathy within the first 5\u00a0months of transplant. Pulmonary post-transplant lymphoproliferative disorder (PTLD) is a particularly aggressive and rapidly progressive disease, with high morbidity and mortality. There are a very limited number of reported pulmonary PTLD cases following HSCT in patients with acute myeloid leukemia (AML). Early diagnosis and detection of pulmonary PTLD is critical given its high lethality. However, variable clinical presentations and nonspecific radiographic findings make pulmonary PTLD difficult to distinguish from other more common causes of pulmonary disease in AML patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here, we describe a 68-year-old Caucasian man who presented for salvage induction therapy following relapse of his AML after a haploidentical allogeneic HSCT 10 months earlier. He developed recurrent fevers, dry cough, and hypoxemia, with chest computed tomography (CT) showing bibasilar consolidations and increased nodularity without increased lymphadenopathy. His symptoms initially improved with antibiotic and antifungal therapy, but his follow-up chest CT showed progression of disease despite symptomatic improvement. Epstein\u2013Barr virus (EBV) was detected in his blood by polymerase chain reaction (PCR), and a lung biopsy revealed monomorphic PTLD with B cells positive for EBV. Unfortunately, the patient\u2019s condition rapidly deteriorated, and he passed away prior to treatment initiation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>\u00a0To our knowledge, this is the first reported case of an AML patient developing pulmonary PTLD relatively late in his post-transplant course in the setting of relapsed disease and salvage therapy. Pulmonary PTLD, a rare but highly lethal disorder, can imitate the symptoms and radiographic findings of pneumonia, a common diagnosis in immunocompromised AML patients. This case illustrates the importance of considering pulmonary PTLD in the differential diagnosis for pulmonary disease in AML patients with a history of HSCT, especially in the setting of progressive radiographic findings despite broad antibacterial and antifungal therapy. Further, our case demonstrates the importance of biopsy and uninterrupted EBV DNA monitoring in the definitive diagnosis of PTLD, given nonspecific symptomatology and radiographic findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-02744-2","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T00:02:57Z","timestamp":1616889777000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epstein\u2013Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Ritika","family":"Dutta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna Y.","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Fernandez-Pol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parveen","family":"Shiraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel N.","family":"Mannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,28]]},"reference":[{"issue":"7","key":"2744_CR1","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.bbmt.2018.02.026","volume":"24","author":"L Liu","year":"2018","unstructured":"Liu L, Zhang X, Feng S. Epstein-Barr virus-related post-transplantation lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2018;24(7):1341\u20139.","journal-title":"Biol Blood Marrow Transplant."},{"issue":"2","key":"2744_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/bmt.2013.96","volume":"49","author":"L Rasche","year":"2014","unstructured":"Rasche L, Kapp M, Einsele H, Mielke S. EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT. Bone Marrow Transplant. 2014;49(2):163\u20137.","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"2744_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/10428194.2018.1474462","volume":"60","author":"S Romero","year":"2019","unstructured":"Romero S, Montoro J, Guinot M, Almenar L, Andreu R, Balaguer A, et al. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation. Leuk Lymphoma. 2019;60(1):142\u201350.","journal-title":"Leuk Lymphoma."},{"issue":"6","key":"2744_CR4","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/cid\/cit391","volume":"57","author":"J Styczynski","year":"2013","unstructured":"Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly JP, van der Velden W, et al. Response to rituximab-based therapy and risk factor analysis in Epstein Barr virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the infectious diseases working party of the European group for blood and marrow transplantation. Clin Infect Dis. 2013;57(6):794\u2013802.","journal-title":"Clin Infect Dis."},{"issue":"7","key":"2744_CR5","first-page":"2208","volume":"94","author":"RE Curtis","year":"1999","unstructured":"Curtis RE, Travis LB, Rowlings PA, Soci\u00e9 G, Kingma DW, Banks PM, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94(7):2208\u201316.","journal-title":"Blood"},{"issue":"20","key":"2744_CR6","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Gilbert ES, Rizzo JD, Soci\u00e9 G, Banks PM, Sobocinski KA, et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood. 2009;113(20):4992\u20135001.","journal-title":"Blood"},{"issue":"4","key":"2744_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/bmt.2008.325","volume":"43","author":"H-A Hou","year":"2009","unstructured":"Hou H-A, Yao M, Tang J-L, Chen Y-K, Ko B-S, Huang S-Y, et al. Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years\u2019 experience in a single institute. Bone Marrow Transplant. 2009;43(4):315\u201321.","journal-title":"Bone Marrow Transplant."},{"issue":"10","key":"2744_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/bmt.2008.394","volume":"43","author":"HCE Buyck","year":"2009","unstructured":"Buyck HCE, Ball S, Junagade P, Marsh J, Chakrabarti S. Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia. Bone Marrow Transplant. 2009;43(10):813\u20136.","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"2744_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/bmt.2008.150","volume":"42","author":"S Ocheni","year":"2008","unstructured":"Ocheni S, Kroeger N, Zabelina T, Sobottka I, Ayuk F, Wolschke C, et al. EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT. Bone Marrow Transplant. 2008;42(3):181\u20136.","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"2744_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3324\/haematol.2016.144428","volume":"101","author":"J Styczynski","year":"2016","unstructured":"Styczynski J, van der Velden W, Fox CP, Engelhard D, de la Camara R, Cordonnier C, et al. Management of Epstein-Barr virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines. Haematologica. 2016;101(7):803\u201311.","journal-title":"Haematologica"},{"issue":"7","key":"2744_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/ajh.23452","volume":"88","author":"Q Liu","year":"2013","unstructured":"Liu Q, Xuan L, Liu H, Huang F, Zhou H, Fan Z, et al. Molecular monitoring and stepwise preemptive therapy for Epstein-Barr virus viremia after allogeneic stem cell transplantation. Am J Hematol. 2013;88(7):550\u20135.","journal-title":"Am J Hematol."},{"issue":"4","key":"2744_CR12","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.3324\/haematol.11142","volume":"92","author":"A Kunitomi","year":"2007","unstructured":"Kunitomi A, Arima N, Ishikawa T. Epstein-barr virus-associated post-transplant lymphoproliferative disorders presented as interstitial pneumonia successful recovery with rituximab. Haematologica. 2007;92(4):e49-52.","journal-title":"Haematologica"},{"issue":"9","key":"2744_CR13","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1164\/rccm.2007-413ST","volume":"183","author":"A Panoskaltsis-Mortari","year":"2011","unstructured":"Panoskaltsis-Mortari A, Griese M, Madtes DK, Belperio JA, Haddad IY, Folz RJ, et al. An official American thoracic society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med. 2011;183(9):1262\u201379.","journal-title":"Am J Respir Crit Care Med."},{"issue":"5","key":"2744_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1440-1673.2006.01618.x","volume":"50","author":"K Burney","year":"2006","unstructured":"Burney K, Bradley M, Buckley A, Lyburn I, Rye A, Hopkins R. Posttransplant lymphoproliferative disorder: a pictorial review. Australas Radiol. 2006;50(5):412\u20138.","journal-title":"Australas Radiol."},{"issue":"2","key":"2744_CR15","doi-asserted-by":"publisher","first-page":"W141","DOI":"10.2214\/AJR.09.3264","volume":"194","author":"A Sauter","year":"2010","unstructured":"Sauter A, Faul C, Bitzer M, Bares R, Kraus S, Fenchel M, et al. Imaging findings in immunosuppressed patients with Epstein Barr virus-related B cell malignant lymphoma. Am J Roentgenol. 2010;194(2):W141\u20139.","journal-title":"Am J Roentgenol."},{"key":"2744_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000954","author":"S Pina-Oviedo","year":"2017","unstructured":"Pina-Oviedo S, Miranda RN, Medeiros LJ. Cancer therapy-associated lymphoproliferative disorders: an under-recognized type of immunodeficiency-associated lymphoproliferative disorder. Am J Surg Pathol. 2017. https:\/\/doi.org\/10.1097\/PAS.0000000000000954.","journal-title":"Am J Surg Pathol."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02744-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-021-02744-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02744-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T00:04:07Z","timestamp":1616889847000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-02744-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,28]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2744"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-02744-2","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,28]]},"assertion":[{"value":"6 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient's family for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}